Morton Coleman, MD
New York, New York, United States
Oncologist in New York City, New York
407 E 70th St #3, New York, NY 10021
About Morton Coleman, MD
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Morton Coleman, MD
During the past decade, Morton Coleman, MD conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
1995-11-01
1999-06-01
Completed
600
High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
1996-04-01
Unknown status
1,000
Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease
1997-01-01
Unknown status
400
Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer
1998-04-01
2005-07-01
Completed
800
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
1997-06-01
Completed
212
Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
1997-03-01
Terminated
469
Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
1997-12-01
2009-03-01
Completed
45
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Morton Coleman, MD
According to Clinical.Site data, the most researched conditions in "Morton Coleman, MD" are
"Breast Cancer" (1 trials), "HER2 Positive Breast Cancer" (1 trials), "Multiple Myeloma" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Morton Coleman, MD" in a lesser frequency.
Clinical Trials Intervention Types at Morton Coleman, MD
Most popular intervention types in "Morton Coleman, MD" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine" (2 trials), "Capecitabine" (1 trials), "Carfilzomib" (1 trials), "Dexamethasone" (1 trials) and "Kanglaite Injection plus gemcitabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Morton Coleman, MD
The vast majority of trials in "Morton Coleman, MD" are
3 trials for "All" genders.
Clinical Trials Status at Morton Coleman, MD
Currently, there are NaN active trials in "Morton Coleman, MD".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Morton Coleman, MD,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Morton Coleman, MD, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".